Search research articles
Contact Us
Filters
Showing results (1-10 of 148) with videos related to
Page
of 15
Sort By:
Plos One
|
January 8, 2020
What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study
Nakyung Jeon, Marco Bortolato
Neuroscience and Biobehavioral Reviews
|
November 27, 2025
Charting the emerging neurosteroid landscape in neuropsychiatry
Marco Bortolato, Graziano Pinna
Journal of Affective Disorders
|
June 10, 2023
Psychological resilience and hyperthymia: Is there a link?
Simona Scheggi, Marco Bortolato
Neuroscience and Biobehavioral Reviews
|
March 4, 2026
The role of neuroactive steroids in psychiatric and neurological disorders: Neurobiology and therapeutic perspectives
Graziano Pinna, Marco Bortolato
Neuropharmacology
|
June 17, 2018
Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
Roberto Frau, Marco Bortolato
Recent Patents on CNS Drug Discovery
|
January 28, 2012
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives
Simone Tambaro, Marco Bortolato
Journal of Neuroscience Methods
|
February 27, 2017
Modeling tics in rodents: Conceptual challenges and paths forward
Marco Bortolato, Christopher Pittenger
Neuroscience and Biobehavioral Reviews
|
March 22, 2024
The role of neuroactive steroids in tic disorders
Caterina Branca, Marco Bortolato
Interdisciplinary Perspectives on Infectious Diseases
|
May 22, 2010
Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects
Marco Bortolato, Sean C Godar
Frontiers in Behavioral Neuroscience
|
May 26, 2022
Editorial: Behavioral Addictions, Risk-Taking, and Impulsive Choice
Marco Bortolato, Gregory J Madden
Page
of 15
Search research articles
Search
Showing results (1-10 of 148) with videos related to
Sort By:
Page
of 15
Plos One
|
January 8, 2020
What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study
Nakyung Jeon, Marco Bortolato
Neuroscience and Biobehavioral Reviews
|
November 27, 2025
Charting the emerging neurosteroid landscape in neuropsychiatry
Marco Bortolato, Graziano Pinna
Journal of Affective Disorders
|
June 10, 2023
Psychological resilience and hyperthymia: Is there a link?
Simona Scheggi, Marco Bortolato
Neuroscience and Biobehavioral Reviews
|
March 4, 2026
The role of neuroactive steroids in psychiatric and neurological disorders: Neurobiology and therapeutic perspectives
Graziano Pinna, Marco Bortolato
Neuropharmacology
|
June 17, 2018
Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
Roberto Frau, Marco Bortolato
Recent Patents on CNS Drug Discovery
|
January 28, 2012
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives
Simone Tambaro, Marco Bortolato
Journal of Neuroscience Methods
|
February 27, 2017
Modeling tics in rodents: Conceptual challenges and paths forward
Marco Bortolato, Christopher Pittenger
Neuroscience and Biobehavioral Reviews
|
March 22, 2024
The role of neuroactive steroids in tic disorders
Caterina Branca, Marco Bortolato
Interdisciplinary Perspectives on Infectious Diseases
|
May 22, 2010
Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects
Marco Bortolato, Sean C Godar
Frontiers in Behavioral Neuroscience
|
May 26, 2022
Editorial: Behavioral Addictions, Risk-Taking, and Impulsive Choice
Marco Bortolato, Gregory J Madden
Page
of 15